Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 244,979 | 269,925 | 207,609 | 221,199 | 238,605 |
| TOTAL | $247,292 | $273,517 | $212,331 | $224,582 | $240,681 |
| Non-Current Assets | |||||
| PPE Net | 3,676 | 3,908 | 4,223 | 4,351 | 4,102 |
| Other Non-Current Assets | 3,454 | 154 | 154 | 154 | 154 |
| TOTAL | $7,130 | $4,062 | $4,377 | $4,505 | $4,256 |
| Total Assets | $254,422 | $277,579 | $216,708 | $229,087 | $244,937 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,424 | 24,939 | 15,898 | 10,331 | 12,068 |
| TOTAL | $19,813 | $45,227 | $36,156 | $30,530 | $32,261 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | 682 | 682 | 682 |
| Deferred Revenues | N/A | 20,288 | 20,258 | 20,199 | 20,193 |
| Other Non-Current Liabilities | 23,788 | 0 | 8 | 6 | 5 |
| TOTAL | $23,788 | $1,699 | $2,529 | $2,641 | $2,702 |
| Total Liabilities | $43,601 | $46,926 | $38,685 | $33,171 | $34,963 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,321 | 36,836 | 33,807 | 33,664 | N/A |
| Common Shares | 4 | 4 | 3 | 3 | 3 |
| Retained earnings | -186,319 | -162,929 | -139,999 | -109,618 | -90,917 |
| TOTAL | $210,821 | $230,653 | $178,023 | $195,916 | $209,974 |
| Total Liabilities And Equity | $254,422 | $277,579 | $216,708 | $229,087 | $244,937 |